$NCSM

Willems Tim sold (to issuer) 27,241 shares of NCSM

Willems Tim (Chief Operations Officer) sold (to issuer) 27,241 shares of NCS Multistage Holdings, Inc. (NCSM) on 2026-09-01.

Original reporting
SEC EDGAR · Willems Tim
Published Sep 1, 2026, 1:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 1:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NCSM
Bearish
medium confidence
Mentioned
$NCSM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NCSMBearishLow
01

Why it matters

The transaction is a routine insider sale with modest share count, unlikely to move the stock significantly.

02

Market read

Provides a fresh, primary source of insider activity; limited trading relevance.

03

What to watch

Absence of price and total value data makes the true impact uncertain.

Relevance 4/10Novelty 4/10Timing: filing date 2026-09-01

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$NCSMBearishMedium confidence
Context

COO Willems Tim sold 27,241 shares of NCSM, leaving a zero holding after the transaction.

Expected impact

Minor short-term price dip, limited to a few basis points.

Evidence & confidence

Small share count and lack of price disclosure limit material impact, but insider exits are generally viewed negatively.

Market effects

No significant sector impact; the sale is company‑specific.

Limited to US investors tracking NCSM.

Minimal global relevance.

Counterpoint

The sale could be a routine liquidity move, not a confidence signal.

Key entities

  • NCS Multistage Holdings, Inc.

    Issuer of the shares sold.

  • Willems Tim

    Chief Operations Officer and reporting insider.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SIONMed

RA CAPITAL MANAGEMENT, L.P. (Kolchinsky Peter, Shah Rajeev M.) sold $21.8M of SION (indirect holdings)

RA CAPITAL MANAGEMENT, L.P. sold 3,448,811 indirectly-held shares of Sionna Therapeutics, Inc. (SION) at an average of $6.33 ($6.32–$7.46, $21.84M total) across 2 trades on 2026-09-17. Filed jointly with RA Capital Healthcare Fund LP (Director), RA Capital Nexus Fund, L.P. (Director), RA Capital Nexus Fund III, L.P. (Director), Kolchinsky Peter (Director) and Shah Rajeev M. (Director).